RHUMBLINE ADVISERS

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in CTMX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$834,427

+$832,852 QoQ

Shares Held

222,514

+17135.8% QoQ

Ownership

0.102%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#54

of 178 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 18% Shared 0% None 82%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. CTMX ranks #150 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$834,427	222,514	+17135.8%	Shares	Sole	2026-08-12
2024-06-30	$1,575	1,291	0.0%	Shares	Sole	2024-08-01
2024-03-31	$2,814	1,291	0.0%	Shares	Sole	2024-05-09
2023-12-31	$2,001	1,291	0.0%	Shares	Sole	2024-02-08
2023-09-30	$1,665	1,291	0.0%	Shares	Sole	2023-11-09
2023-06-30	$2,220	1,291	-98.1%	Shares	Sole	2023-08-08
2022-03-31	$179,893	67,376	+0.6%	Shares	Sole	2022-05-12
2021-12-31	$289,884	66,948	-1.4%	Shares	Sole	2022-02-10
2021-09-30	$345,778	67,933	+5.9%	Shares	Sole	2021-11-12
2021-06-30	$406,234	64,176	+5.2%	Shares	Sole	2021-08-05
2021-03-31	$471,421	60,986	+3.1%	Shares	Sole	2021-05-06
2020-12-31	$387,373	59,141	+5.9%	Shares	Sole	2021-02-10
2020-09-30	$371,276	55,831	-12.2%	Shares	Sole	2020-11-12
2020-06-30	$529,962	63,621	+4.9%	Shares	Sole	2020-08-13
2020-03-31	$465,300	60,665	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.